XML 30 R21.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Reporting
 9 Months Ended
Mar. 31, 2020
Segment Reporting [Abstract]  
Segment Reporting

15. Segment Reporting

 

Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated on a regular basis by the chief operating decision-maker ("CODM") in deciding how to allocate resources to an individual segment and in assessing performance of the segment. The Company operates in two segments – the Surgical and the Wound segment. The Company has concluded that its Chief Executive Officer is the CODM as he is the ultimate decision maker for key operating decisions, determining the allocation of resources and assessing the financial performance of the Company. The CODM evaluates the segments using gross profit and gross profit margin. The Company does not allocate its assets by segment, and therefore does not disclose assets by segment.

 

Segment gross profit and gross profit margin include:

 

For the three months ended March 31, 2020  Surgical   Wound   Consolidated 
             
Total revenue  $9,102,711   $8,799,801   $17,902,512 
                
Gross profit  $6,175,222   $6,415,725   $12,590,947 
Gross profit %   67.8%   72.9%   70.3%
                
For the nine months ended March 31, 2020               
                
Total revenue  $28,702,566   $20,067,853   $48,770,419 
                
Gross profit  $19,588,322   $14,688,776   $34,277,098 
Gross profit %   68.2%   73.2%   70.3%

                
For the three months ended March 31, 2019    Surgical      Wound      Consolidated  
                
Total revenue  $8,267,510   $1,289,080   $9,556,590 
                
Gross profit  $5,783,062   $971,957   $6,755,019 
Gross profit %   69.9%   75.4%   70.7%
                
For the nine months ended March 31, 2019               
                
Total revenue  $25,039,057   $4,055,151   $29,094,208 
                
Gross profit  $17,413,031   $3,080,983   $20,494,014 
Gross profit %   69.5%   76.0%   70.4%

  

Worldwide revenue for the Company's product revenue is categorized as follows:

 

   For the three months ended   For the nine months ended 
   March 31   March 31 
   2020   2019   2020   2019 
                 
Domestic  $14,778,416   $5,409,778   $36,582,037   $16,897,657 
International   3,124,096    4,146,812    12,188,382    12,196,551 
Total  $17,902,512   $9,556,590   $48,770,419   $29,094,208 

  

Substantially all of the Company's long-lived assets are located in the United States.